Vimedimex Medi-Pharma JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	124,646	301,122	209,806	213,681	148,753	302,726
Short-Term Investments	242,580	33,960	39,649	42,695	31,158	31,215
Cash & Short-Term Investments	367,227	335,082	249,455	256,375	179,911	333,941
Cash Growth	-	34.33%	-2.70%	42.50%	-46.13%	109.28%
Accounts Receivable	248,604	304,464	646,417	1,141,641	2,000,498	3,278,486
Other Receivables	183,320	396,513	406,871	163,986	163,544	160,756
Receivables	431,923	700,977	1,053,288	1,305,626	2,164,042	3,439,242
Inventory	78,747	84,864	247,076	947,132	2,531,669	3,765,268
Prepaid Expenses	259.59	1,762	1,617	4,175	2,896	3,563
Other Current Assets	43,720	47,808	62,826	299,011	401,119	502,135
Total Current Assets	921,877	1,170,493	1,614,262	2,812,320	5,279,637	8,044,149
Property, Plant & Equipment	106,747	110,781	134,506	132,700	146,847	136,864
Long-Term Investments	8,991	8,991	7,931	7,931	6,551	6,551
Other Intangible Assets	29,126	31,827	17,313	18,168	18,818	19,511
Long-Term Deferred Tax Assets	-	-	-	-	94.93	94.93
Other Long-Term Assets	66,274	69,496	76,284	82,402	79,558	85,681
Total Assets	1,133,014	1,391,589	1,850,296	3,053,522	5,531,506	8,292,851
Accounts Payable	520,163	598,577	1,063,506	1,908,699	4,183,257	7,376,154
Accrued Expenses	19,094	9,816	9,797	17,043	221,264	10,162
Short-Term Debt	-	-	-	-	612,374	345,000
Current Income Taxes Payable	2,211	4,811	3,489	5,880	-	5,009
Current Unearned Revenue	-	-	224.02	151.5	-	123.38
Other Current Liabilities	147,183	342,390	332,149	682,301	94,179	186,650
Total Current Liabilities	688,651	955,594	1,409,165	2,614,073	5,111,074	7,923,099
Other Long-Term Liabilities	18,747	18,327	20,077	20,746	23,664	24,625
Total Liabilities	707,397	973,920	1,429,242	2,634,819	5,134,738	7,947,724
Common Stock	154,403	154,403	154,403	154,403	154,403	154,403
Additional Paid-In Capital	114,168	114,168	114,168	114,168	114,168	114,168
Retained Earnings	69,342	60,239	64,348	71,623	53,266	70,149
Comprehensive Income & Other	9,262	9,262	9,262	9,262	8,206	6,407
Total Common Equity	347,175	338,072	342,181	349,456	330,042	345,127
Minority Interest	78,442	79,597	78,873	69,246	66,726	-
Shareholders' Equity	425,617	417,669	421,054	418,702	396,768	345,127
Total Liabilities & Equity	1,133,014	1,391,589	1,850,296	3,053,522	5,531,506	8,292,851
Total Debt	-	-	-	-	612,374	345,000
Net Cash (Debt)	367,227	335,082	249,455	256,375	-432,463	-11,059
Net Cash Growth	-	34.33%	-2.70%	-	-	-
Net Cash Per Share	23779.80	21698.27	16152.32	16604.34	-28008.76	-716.24
Filing Date Shares Outstanding	15.44	15.44	15.44	15.44	15.44	15.44
Total Common Shares Outstanding	15.44	15.44	15.44	15.44	15.44	15.44
Working Capital	233,226	214,900	205,097	198,247	168,563	121,050
Book Value Per Share	22485.07	21895.46	22161.60	22633.91	21375.44	22352.40
Tangible Book Value	318,050	306,244	324,868	331,288	311,224	325,616
Tangible Book Value Per Share	20598.72	19834.14	21040.32	21457.18	20156.64	21088.79
Buildings	79,524	-	77,896	77,896	79,708	77,323
Machinery	120,187	-	120,033	108,504	108,463	106,460
Construction In Progress	34,658	33,905	46,972	41,385	40,563	19,677

Source: S&P Global Market Intelligence. Standard template. Financial Sources.